Hepatitis C Information Central

Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

News, Updates and Commentary

Free Newsletter

We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS

Hepatitis C: Are you at risk?
What is known is that around 4 million Americans are infected with Hepatitis C virus.What is not known is how many Americans have it. Are you one of them?Here are the indicators on how you could be infected:Did you have a blood transfusion, blood

National Committee leads World Hepatitis Day campaign in Egypt
On this day, the public will have free access to HBV and HCV screening, HBV vaccination, abdominal ultrasound exams, consultations with renowned hepatologists and awareness seminars, all of which take place at Al Azhar Park. National celebrities

Hepatitis C outbreak linked to reused syringes
Hepatitis C outbreak linked to reused syringes Reported by: Last Update: 5/12 8:25 pm SALT LAKE CITY (ABC 4 News) - There's a new health warning out about Hepatitis-C and re-used syringes. There are 77 new cases of Hepatitis-C in Nevada because of a

UPDATES AND COMMENTARY

New Mexico Offers Free Hepatitis C Hotline
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Ribavirin/Rebetron

Ribavirin Treatment of HCV	Ribavirin approved for combo treatment
Ribavirin Interferon Combination with phlebotomy	What is Rebetron? (Facts)
IFN Alfa-2b Plus Ribavirin Combination Increases Sustained Response Rate	Ribavirin Treatment alone or in combination with Interferon
Phase III results of Interferon & Rebetol	FDA approves Rebetron Combination Therapy
Long term efficacy of Ribavirin plus interferon alfa	Interferon, Ribavirin and Actigall
Hepatitis C: Important Treatment Advance: Interview with Douglas Dieterich, MD	Schering Submits Supplemental NDA for REBETRON(TM)
Ribavirin Info Sheet	New Therapy Packs Powerful One-Two Punch Against HCV
A randomized study comparing ribavirin and interferon alfa monotherapy for Hepatitis C recurrence after liver transplantation	Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover
Rebetol(TM) Plus Intron (Interferon)A	Treatment response in chronic Hepatitis C. Content of virus in serum is decisive for the outcome
Effect of ribavirin on virus load and quasispecies distribution in patients infected with Hepatitis C virus	Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic Hepatitis C not responding to interferon alone
Ribavirin monotherapy in patients with chronic Hepatitis C	Ribavirin in Hepatitis C related cryoglobulinemia
Adding ribavirin to interferon alpha-2b for chronic Hepatitis C infection increased virological response and nausea	Interferon alpha with ribavirin for the treatment of chronic Hepatitis C in non-responders or relapsers to interferon monotherapy
Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic Hepatitis C patients	Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover
Schering-Plough Reports Results of Clinical Studies of REBETRON(TM) Combination Therapy for Hepatitis C at American Association for the Study of Liver Diseases Meeting	Two Drugs Are Better for Hepatitis
Studies Show Significant Increase in Rate of Sustained Response With Combination Therapy as Compared to Standard Treatment	Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
r-Interferon Alfa-2b/Ribavirin Combined Therapy Followed by Low-Dose r-Interferon Alfa-2b in Chronic Hepatitis C Interferon Nonresponders	New Warnings Placed On Rebetron Hepatitis Therapy
Quantification of Serum Hepatitis C Virus RNA	Rebetron Safety Information

Table of Contents

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.